Bio-Rad Laboratories, Inc.
BIO
株式のランク
#2167
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
株価
$353.86
時価総額
$9.46B
変化（1日）
0.51%
変化（1年）
9.93%
国
US
取引 Bio-Rad Laboratories, Inc. (BIO)
カテゴリー
Healthcare
Bio-Rad Laboratories, Inc.（BIO）のP/E比率
October 2026 時点のP/E比率 TTM 43.51
Bio-Rad Laboratories, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 43.51 です。2023 年末時点での P/E は -14.80 でした。
Bio-Rad Laboratories, Inc. の P/E 比率の履歴（2000 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 43.51 | -964.99% |
| 2024 | -5.03 | -66.04% |
| 2023 | -14.80 | 328.61% |
| 2022 | -3.45 | -165.17% |
| 2021 | 5.30 | 16.45% |
| 2020 | 4.55 | -27.54% |
| 2019 | 6.28 | -67.28% |
| 2018 | 19.19 | -68.89% |
| 2017 | 61.69 | -67.67% |
| 2016 | 190.80 | 433.20% |
| 2015 | 35.78 | -8.68% |
| 2014 | 39.18 | -13.74% |
| 2013 | 45.42 | 158.67% |
| 2012 | 17.56 | 16.26% |
| 2011 | 15.11 | -2.48% |
| 2010 | 15.49 | -15.26% |
| 2009 | 18.28 | -19.87% |
| 2008 | 22.81 | -23.37% |
| 2007 | 29.77 | 41.23% |
| 2006 | 21.08 | 0.79% |
| 2005 | 20.91 | -3.29% |
| 2004 | 21.63 | 12.38% |
| 2003 | 19.24 | 34.25% |
| 2002 | 14.33 | -18.83% |
| 2001 | 17.66 | 41.42% |
| 2000 | 12.49 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 33.11 | -23.90% |
US
|
|
| 21.39 | -50.84% |
IE
|
|
| 28.94 | -33.47% |
US
|
|
| 17.34 | -60.15% |
US
|
|
| - | - |
DE
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。